Clinical Management of Primary Aldosteronism: An Update.
Rossi GP, Rossi FB, Guarnieri C, Rossitto G, Seccia TM.
Hypertension. 2024 Sep;81(9):1845-1856. doi: 10.1161/HYPERTENSIONAHA.124.22642. Epub 2024 Jul 24.
Aldosterone as a Mediator of Cardiovascular Damage.
Buffolo F, Tetti M, Mulatero P, Monticone S.
Hypertension. 2022 Sep;79(9):1899-1911. doi: 10.1161/HYPERTENSIONAHA.122.17964. Epub 2022 Jun 29.
The Effect of Aldosterone on Cardiorenal and Metabolic Systems.
Otsuka H, Abe M, Kobayashi H.
Int J Mol Sci. 2023 Mar 11;24(6):5370. doi: 10.3390/ijms24065370.
Myocardial mechano-energetic efficiency in primary aldosteronism.
Salvetti M, Paini A, Bertacchini F, Aggiusti C, Stassaldi D, Capellini S, Arnoldi C, Rizzoni D, Agabiti Rosei C, De Ciuceis C, Muiesan ML.
J Hypertens. 2021 Feb 1;39(2):318-324. doi: 10.1097/HJH.0000000000002637.
Low sodium intake ameliorates hypertension and left ventricular hypertrophy in mice with primary aldosteronism.
Wang Z, Zhao X, Bu L, Liu K, Li Z, Zhang H, Zhang X, Yuan F, Wang S, Guo Z, Shi L.
Front Physiol. 2023 Feb 15;14:1136574. doi: 10.3389/fphys.2023.1136574. eCollection 2023.
Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Lin YH, Wu XM, Lee HH, Lee JK, Liu YC, Chang HW, Lin CY, Wu VC, Chueh SC, Lin LC, Lo MT, Ho YL, Wu KD; TAIPAI Study Group.
J Hypertens. 2012 Aug;30(8):1606-13. doi: 10.1097/HJH.0b013e3283550f93.
Electrical and Myocardial Remodeling in Primary Aldosteronism.
Curione M, Petramala L, Savoriti C, Verrenti M, Baiocco E, Salvatore S, Zinnamosca L, Iannucci G, Sciomer S, Letizia C.
Front Cardiovasc Med. 2014 Nov 6;1:7. doi: 10.3389/fcvm.2014.00007. eCollection 2014.
Preclinical cardiac disease in women and men with primary aldosteronism.
Aune A, Kokorina M, Grytaas MA, Midtbø H, Løvås K, Gerdts E.
Blood Press. 2021 Aug;30(4):230-236. doi: 10.1080/08037051.2021.1904775. Epub 2021 Mar 30.
Impact of Adrenalectomy on Diastolic Cardiac Dysfunction in Patients with Primary Aldosteronism.
Nezu K, Kawasaki Y, Morimoto R, Ono Y, Omata K, Tezuka Y, Shimada S, Satake Y, Katayama H, Sato T, Kawamorita N, Yamashita S, Takahama H, Mitsuzuka K, Satoh F, Ito A.
Tohoku J Exp Med. 2023 Feb 21;259(3):229-236. doi: 10.1620/tjem.2022.J117. Epub 2022 Dec 29.
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
Weber KT, Brilla CG, Campbell SE, Zhou G, Matsubara L, Guarda E.
Blood Press. 1992 Aug;1(2):75-85. doi: 10.3109/08037059209077497.
